SPL 9.09% 12.0¢ starpharma holdings limited

6 months in - CEO Report card, page-4

  1. 3,532 Posts.
    lightbulb Created with Sketch. 846
    The share price has continued to sink deeper into the toilet since CM was appointed CEO but I see this as simply negative momentum, exemplified by some average legacy announcements and developments, capitulation by some shareholders as well as EOFY tax loss selling pressure.

    I think the CEO has been given some slack so far. And deservedly so. She was handed a complete dog’s breakfast to clean up and I think she has done remarkably well so far to reset the agenda including setting much more realistic hopes and dreams for shareholders.

    Everyone should be thankful to now know (post webinar) what programs are being continued and prioritised, which ones are on life support and which ones are now dead and buried. Poor shareholders had been punching in the dark for years.

    This is CM’s baby now. It’s reasonable that the grace period is now over. Going forward, CM should be accountable for the share price, operational developments and results of publicly stated aims.

 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
12.0¢
Change
0.010(9.09%)
Mkt cap ! $50.17M
Open High Low Value Volume
11.0¢ 12.0¢ 11.0¢ $127.2K 1.070M

Buyers (Bids)

No. Vol. Price($)
4 130918 11.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.5¢ 103000 3
View Market Depth
Last trade - 16.10pm 19/11/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.